- Home
- Pathology Industry
- Growth Hormone Market and Forecasts, May 2013
Industries
- Pathology (170)
- Drug and Medication (160)
- Fruit and Vegetable (143)
- Agrochemical (98)
- Biotechnology (89)
-
- Agriculture (80)
- Fish and Seafood (78)
- Meat and Poultry (72)
- Biopharmaceutical (65)
- Energy & Environment (58)
- Skin Care Products (53)
- Dairy Products and Egg (52)
- Food (46)
- Fertilizer (45)
- Pesticide (38)
- In Vitro Diagnostic (29)
- Water Distribution and Treatment (29)
- Livestock (24)
- Diagnostics (22)
- Genomics (22)
Top countries
- United States (552)
- India (190)
- World (134)
- China (114)
- Canada (102)
-
- Australia (88)
- Europe (67)
- Japan (30)
- Iran (29)
- Ireland (29)
- Germany (28)
- Brazil (28)
- United Kingdom (27)
- Nigeria (23)
- Malaysia (21)
- Africa (21)
- Pakistan (19)
- Philippines (19)
- Russian Federation (19)
- South Korea (18)
Publication dates
All regions
-
- Algeria (2)
- Benin (2)
- Botswana (1)
- Cameroon (1)
- Chad (1)
- Egypt (15)
- Ethiopia (6)
- Ghana (4)
- Kenya (5)
- Libyan Arab Jamahiriya (1)
- Madagascar (1)
- Malawi (1)
- Mauritius (3)
- Morocco (2)
- Namibia (5)
- Niger (2)
- Nigeria (23)
- Sierra Leone (1)
- South Africa (14)
- Sudan (2)
- Swaziland (3)
- Tanzania (3)
- Tunisia (1)
- Zimbabwe (2)
-
- Afghanistan (1)
- Azerbaijan (1)
- Bangladesh (6)
- Bhutan (1)
- China (114)
- Georgia (4)
- India (190)
- Indonesia (9)
- Iran (29)
- Iraq (2)
- Israel (2)
- Japan (30)
- Jordan (2)
- Kazakhstan (2)
- Laos (1)
- Lebanon (3)
- Malaysia (21)
- Nepal (1)
- Oman (1)
- Pakistan (19)
- Philippines (19)
- Saudi Arabia (11)
- Singapore (8)
- South Korea (18)
- Sri Lanka (2)
- Syrian Arab Republic (1)
- Taiwan (6)
- Thailand (15)
- Turkey (13)
- Vietnam (6)
-
- Albania (1)
- Austria (3)
- Belgium (5)
- Bulgaria (2)
- Cyprus (1)
- Czech Republic (3)
- Denmark (11)
- Estonia (1)
- Finland (7)
- France (9)
- Germany (28)
- Greece (9)
- Hungary (1)
- Iceland (3)
- Ireland (29)
- Italy (16)
- Latvia (1)
- Lithuania (3)
- Luxembourg (1)
- Macedonia (4)
- Netherlands (10)
- Norway (6)
- Poland (5)
- Portugal (1)
- Romania (5)
- Russian Federation (19)
- San Marino (1)
- Serbia and Montenegro (4)
- Slovenia (1)
- Spain (8)
- Sweden (6)
- Switzerland (9)
- Ukraine (1)
- United Kingdom (27)
-
- Australia (88)
- Austria (3)
- Belgium (5)
- Canada (102)
- Chile (6)
- Czech Republic (3)
- Denmark (11)
- Estonia (1)
- Finland (7)
- France (9)
- Germany (28)
- Greece (9)
- Hungary (1)
- Iceland (3)
- Ireland (29)
- Israel (2)
- Italy (16)
- Japan (30)
- Luxembourg (1)
- Mexico (2)
- Netherlands (10)
- New Zealand (10)
- Norway (6)
- Poland (5)
- Portugal (1)
- Slovenia (1)
- South Korea (18)
- Spain (8)
- Sweden (6)
- Switzerland (9)
- Turkey (13)
- United Kingdom (27)
- United States (552)
data types
- All
- Industry Data
- Company Data (1 145)
- Country Data (518)
Growth Hormone Market and Forecasts, May 2013
You might be interested in: hormone, human growth hormone, injectable delivery, more »
industry reports
country reports
Growth Hormone Sector in The United States
- Industry report
- March 2012
- 11 pages
... When first created, ghrh11002/h11002 mice were named laron mice, because they seemed to share common cause and defects that include deficiency in growth hormone signaling and congenital igf ...
- Industries: Biopharmaceutical
- Countries: United States
Biopharmaceutical Market (biopharmaceutical, growth hormone, biogeneric) in Australia, China and India
- Industry report
- March 2012
- 2 pages
- by Corporation
... Gen focuses in the areas of gastroenterology, endocrinology and immunology. Its product portfolio includes therapeutics such as rhuman growth hormone, rhuman insulin and gcsf. Scigen has acquired the rights ...
- Industries: Biopharmaceutical
- Countries: Australia, China, India
Biopharmaceutical Sector (biopharmaceutical, growth hormone, biogeneric) in Australia, China and India
- Industry report
- March 2012
- 2 pages
... Gen focuses in the areas of gastroenterology, endocrinology and immunology. Its product portfolio includes therapeutics such as rhuman growth hormone, rhuman insulin and gcsf. Scigen has acquired the rights ...
- Industries: Biopharmaceutical
- Countries: Australia, China, India
Biopharmaceutical Business (biopharmaceutical, growth hormone, biogeneric) in Australia, India and Singapore
- Industry report
- June 2012
- 2 pages
... Of gastroenterology, endocrinology and immunology. Its product portfolio includes therapeutics such as rhuman growth hormone, rhuman insulin and gcsf. Scigen has acquired the rights to manufacture, distribute ...
- Industries: Biopharmaceutical
- Countries: Australia, India, Singapore
Biopharmaceutical Industry (biopharmaceutical, growth hormone) in Australia, Singapore and India
- Industry report
- June 2012
- 2 pages
... Portfolio includes therapeutics such as rhuman growth hormone, rhuman insulin and gcsf. ______________________________________________________________________ Scigen limited arbn 101 318 852 suite 1, 13b ...
- Industries: Biopharmaceutical
- Countries: Australia, Singapore, India
The Australian Biopharmaceutical Industry Brief (biopharmaceutical, interferon alpha, growth hormone)
- Industry report
- January 2012
- 2 pages
- by Corporation
... Therapeutics such as rhuman growth hormone, rhuman insulin, gcsf and interferon alpha 2b. For personal use only ______________________________________________________________________ scigen limited arbn 101 ...
- Industries: Biopharmaceutical
- Countries: Australia
Hepatitis B Vaccine Market (hepatitis b vaccine, growth hormone, biogeneric) in Australia
- Industry report
- November 2011
- 2 pages
- by Corporation
... And immunology. Its product portfolio includes therapeutics such as rhuman growth hormone, rhuman insulin and gcsf. Scigen has acquired the rights to manufacture, distribute and market biopharmaceutical ...
- Industries: Biopharmaceutical
- Countries: Australia
The Taiwanese Biosimilar Sector (biosimilar, protein, human growth hormone)
- Industry report
- September 2011
- 41 pages
... Human growth hormone Recombinant human insulin Recombinant human gcsf Recombinant human epo 222222 scope Well-characterized recombinant peptides and protein products. Vaccines, allergen, blood ...
- Industries: Biopharmaceutical
- Countries: Taiwan
Biopharmaceutical Sector Brief
- Industry report
- July 2012
- 16 pages
... Cost is driving much of the growth, and as a result, many countries have implemented policies and regulations that allow for increased competition through the entry of cheaper, similar biological ...
- Industries: Biopharmaceutical
Global Biopharmaceutical : Innovation and Technology Trends
- Industry report
- January 2012
- 15 pages
... Of production and the process by which they are synthesized. Biopharmaceuticals are synthesized using biologic components such as monoclonal antibodies, proteins, hormones, nucleic acids, colony stimulating ...
- Industries: Biopharmaceutical
- Countries: World
» Read our Company Profiles
4 Companies for Growth HormoneBig Island Tropical Flower Farms
United StatesCitrix
United StatesAccessEd
AustraliaMaterials and Methods
United StatesReportlinker.com © Copyright 2013. All rights reserved.
